Report for the third quarter of 2020
July – September in brief · Net sales totaled SEK 14,216 (24,279) thousand. Adjusted for acquired sales, bioprocess sales in 2019 and changes in exchange rates, growth rose by 18%. · Gross profit totaled SEK 15,487 (20,814) thousand. · Operating profit before depreciation and amortization (EBITDA) totaled SEK 3,262 (7,987) thousand. · Operating result totaled SEK 1,715 (7,019) thousand. · Comprehensive income was SEK 662 (7,473) thousand. · Comprehensive income per share, basic and diluted, totaled SEK 0.01 (0.12). · Cash flow from operating activities was SEK 1,191 (